BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8811523)

  • 21. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans.
    Carriere F; Barrowman JA; Verger R; Laugier R
    Gastroenterology; 1993 Sep; 105(3):876-88. PubMed ID: 8359655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
    Mascarenhas MR; Mondick J; Barrett JS; Wilson M; Stallings VA; Schall JI
    J Clin Pharmacol; 2015 Aug; 55(8):854-65. PubMed ID: 25689042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of steatocrit and fat absorption in persons with cystic fibrosis.
    Wagner MH; Bowser EK; Sherman JM; Francisco MP; Theriaque D; Novak DA
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):202-5. PubMed ID: 12187298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
    Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
    Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interdigestive and postprandial duodenal pH in healthy probands, in patients with ulcer and in chronic pancreatitis].
    Gerber B; Gerber S; Arendt R
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(4):158-64. PubMed ID: 2830092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.
    Savarino V; Mela GS; Zentilin P; Mele MR; Lapertosa L; Patetta R; Dallorto E; Vassallo A; Mansi C; Vigneri S; Celle G
    Gut; 1996 Oct; 39(4):508-12. PubMed ID: 8944557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL; Fine DR; Batten JC; Northfield TC
    Gut; 1985 Sep; 26(9):892-901. PubMed ID: 3849459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic Enzyme Replacement Therapy and Coefficient of Fat Absorption in Children and Adolescents With Cystic Fibrosis.
    Woestenenk JW; van der Ent CK; Houwen RH
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):355-60. PubMed ID: 25782658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL; Assoufi BA; Balasubramanian K; Cornell S; Benoliel D; Northfield TC; Hodson ME
    Pancreas; 1992; 7(3):311-9. PubMed ID: 1594552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
    Robb TA; Davidson GP; Kirubakaran C
    Gut; 1985 Nov; 26(11):1246-56. PubMed ID: 4065698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiological responses to meals in the Zollinger-Ellison syndrome: 2. Gastric emptying and its effect on duodenal function.
    Malagelada JR
    Gut; 1980 Feb; 21(2):98-104. PubMed ID: 7380344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intragastric acid-resistant lipase activity and lipolysis in pancreatic steatorrhoea due to cystic fibrosis.
    Balasubramanian K; Zentler-Munro PL; Batten JC; Northfield TC
    Pancreas; 1992; 7(3):305-10. PubMed ID: 1594551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Ceppa P; Vigneri S; Mele MR; Mansi C; Tracci D; Bisso G; Celle G
    Gastroenterology; 1997 Sep; 113(3):741-5. PubMed ID: 9287963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial gastric function in pancreatic insufficiency.
    Regan PT; Malagelada JR; Dimagno EP; Go VL
    Gut; 1979 Mar; 20(3):249-54. PubMed ID: 35448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L; Rodríguez R; Guarner F; Malagelada JR
    Gut; 1993 May; 34(5):708-12. PubMed ID: 8504976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors that affect the performance of lipase on fat digestion and absorption in a canine model of pancreatic insufficiency.
    Meyer JH; Gu YG; Jehn D; Doty JE
    Pancreas; 1994 Sep; 9(5):613-23. PubMed ID: 7809016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.